Something To Consider Today
One company to consider adding to your watch list is Mannkind, MNKD. Upgraded to "market outperform" at Motley Fool yesterday.
Company has secured financing to operate through Afrezza's approval. A big pharma partnership could happen at any time.
At under $2.00 a share currently now may be a good time to add a few shares to your portfolio for the approval run-up.